wip These pages are work in progress. Please add comments if you want. If you have material to submit send them to me via admin@wmsurgeons.com

Search:     Advanced search
Browse by category:
Contact Us

Can you tell me about the staging of breast cancer?

Author:Lengyel J.
on 01 Jun, 2007

Last edited by: Lengyel J. on 01 Jun, 2007
Add comment
Views: 706
Votes: 3
Comments: 0
Breast cancer pathology
 
Lymph node status
 
10 year survival 
no nodes = 75%
nodes involved = 25% ( More nodes the worst the prognosis)
 
sentinel node biopsy
 
 
Tumour size
 
Time dependent
Tumours > 15mm have a 40% risk of LN +ve
Tumours <15mm have a 0-15% risk of LN +ve
 
 
Differentiation
 
Nottingham method
Grade 1 tumour = 85% 10 year survival
Grade 3 tumour = 45% 10 year survival
 
E2 / Progesterone
 
30 % patients will respond to endocrine therapy
60% patients with ER +ve tumours respond
78% patients with ER /PR +ve tumours respond
 
BRCA1 and BRCA2
BRCA1 are usually medullary carcinomas, less likely yo be ERE/PR +ve and are of high grade, higher p53
 
HER-2
HER-2 overexpression in LN+ve cancers carries a bad prognosis
HER-2 and LN-ve cancers….no consensus
 
 
 Stage
 
1                    T1 <2cm               N0                                           90%
2                    T2 2-5cm              N1 mobile nodes                   70%
3                    T3 >5cm               N2 Fixed nodes                     50%   
4                    Fixed any size     N3 supraclav nodes              < 20%
Others in this Category
document Sentinel node biospy summary
document Do you know the TNM staging system for Breast cancer?
document What is the role of the axilla in breast surgery?
document What is the best tumour marker for Breast cancer
document What is Herceptin? Is there any evidence to support its use?
document What are the guidelines for screening for familial breast cancer?
document What are the current treatment guidelines for breast cancer?
document Whatr are the components of the Nottingham Prognostic index?
document How effective is herceptin?
document ALMANAC trial



RSS